Hanen Samouda1, Carine De Beaufort2, Saverio Stranges1, Marco Hirsch3, Jean-Paul Van Nieuwenhuyse4, Georges Dooms4, Georges Gilson5, Olivier Keunen6, Sonia Leite7, Michel Vaillant8, Marie-Lise Lair1,8, Frédéric Dadoun1,9. 1. Population Health Department, Center for Health Studies, Luxembourg Institute of Health, Strassen, Luxembourg. 2. Diabetes & Endocrinology Care Clinique Pédiatrique (DECCP), Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. 3. Rheumatology Department, ZithaKlinik, Luxembourg, Luxembourg. 4. Radiology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. 5. Department of Clinical Biology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. 6. Norlux Neuro-Oncology Laboratory, Luxembourg Institute of Health, Strassen, Luxembourg. 7. Centre of Competence for Methodology and Statistics (CCMS), Luxembourg Institute of Health, Strassen, Luxembourg. 8. Santé et Prospectives, Sanem, Luxembourg. 9. Endocrinology and Diabetology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
Abstract
BACKGROUND: Childhood obesity is associated with early cardiometabolic risk (CMR), increased risk of adulthood obesity, and worse health outcomes. Leg fat mass (LFM) is protective beyond total fat mass (TFM) in adults. However, the limited evidence in children remains controversial. OBJECTIVE: We investigated the relationship between LFM and CMR factors in youth. SUBJECTS: A total of 203 overweight/obese children, 7-17-yr-old, followed in the Pediatric Clinic, Luxembourg. METHODS: TFM and LFM by dual energy x-ray absorptiometry and a detailed set of CMR markers were analyzed. RESULTS: After TFM, age, sex, body mass index (BMI) Z-score, sexual maturity status, and physical activity adjustments, negative significant partial correlations were shown between LFM and homeostasis model assessment of insulin resistance (HOMA) (variance explained: 6.05% by LFM*; 7.18% by TFM**), fasting insulin (variance explained: 5.71% by LFM*; 6.97% by TFM**), triglycerides (variance explained: 3.96% by LFM*; 2.76% by TFM*), systolic blood pressure (variance explained: 2.68% by LFM*; 4.33% by TFM*), C-reactive protein (variance explained: 2.31% by LFM*; 4.28% by TFM*), and resistin (variance explained: 2.16% by LFM*; 3.57% by TFM*). Significant positive partial correlations were observed between LFM and high-density lipoprotein (HDL) cholesterol (variance explained: 4.16% by LFM*) and adiponectin (variance explained: 3.09% by LFM*) (*p-value < 0.05 and **p-value < 0.001). In order to adjust for multiple testing, Benjamini-Hochberg method was applied and the adjusted significance level was determined for each analysis. LFM remained significant in the aforementioned models predicting HOMA, fasting insulin, triglycerides, and HDL cholesterol (Benjamini and Hochberg corrected p-value < 0.01). CONCLUSIONS: LFM is protective against CMR in children, at least in terms of insulin resistance and adverse blood lipid profiles.
BACKGROUND: Childhood obesity is associated with early cardiometabolic risk (CMR), increased risk of adulthood obesity, and worse health outcomes. Leg fat mass (LFM) is protective beyond total fat mass (TFM) in adults. However, the limited evidence in children remains controversial. OBJECTIVE: We investigated the relationship between LFM and CMR factors in youth. SUBJECTS: A total of 203 overweight/obesechildren, 7-17-yr-old, followed in the Pediatric Clinic, Luxembourg. METHODS: TFM and LFM by dual energy x-ray absorptiometry and a detailed set of CMR markers were analyzed. RESULTS: After TFM, age, sex, body mass index (BMI) Z-score, sexual maturity status, and physical activity adjustments, negative significant partial correlations were shown between LFM and homeostasis model assessment of insulin resistance (HOMA) (variance explained: 6.05% by LFM*; 7.18% by TFM**), fasting insulin (variance explained: 5.71% by LFM*; 6.97% by TFM**), triglycerides (variance explained: 3.96% by LFM*; 2.76% by TFM*), systolic blood pressure (variance explained: 2.68% by LFM*; 4.33% by TFM*), C-reactive protein (variance explained: 2.31% by LFM*; 4.28% by TFM*), and resistin (variance explained: 2.16% by LFM*; 3.57% by TFM*). Significant positive partial correlations were observed between LFM and high-density lipoprotein (HDL) cholesterol (variance explained: 4.16% by LFM*) and adiponectin (variance explained: 3.09% by LFM*) (*p-value < 0.05 and **p-value < 0.001). In order to adjust for multiple testing, Benjamini-Hochberg method was applied and the adjusted significance level was determined for each analysis. LFM remained significant in the aforementioned models predicting HOMA, fasting insulin, triglycerides, and HDL cholesterol (Benjamini and Hochberg corrected p-value < 0.01). CONCLUSIONS: LFM is protective against CMR in children, at least in terms of insulin resistance and adverse blood lipid profiles.
Authors: Megan Hetherington-Rauth; Jennifer W Bea; Vinson R Lee; Robert M Blew; Janet L Funk; Timothy G Lohman; Scott B Going Journal: Am J Hum Biol Date: 2018-08-20 Impact factor: 1.937
Authors: Liwang Gao; Hong Cheng; Yinkun Yan; Junting Liu; Xinying Shan; Xi Wang; Jie Mi Journal: Front Endocrinol (Lausanne) Date: 2022-09-15 Impact factor: 6.055
Authors: Catherine E Cioffi; Jean A Welsh; Jessica A Alvarez; Terryl J Hartman; K M Venkat Narayan; Miriam B Vos Journal: Curr Dev Nutr Date: 2019-11-13